Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.
Murphy A, Nestor LJ, McGonigle J, Paterson L, Boyapati V, Ersche KD, Flechais R, Kuchibatla S, Metastasio A, Orban C, Passetti F, Reed L, Smith D, Suckling J, Taylor E, Robbins TW, Lingford-Hughes A, Nutt DJ, Deakin JFW, Elliott R; ICCAM Platform. Murphy A, et al. Among authors: deakin jfw. Neuropsychopharmacology. 2017 Aug;42(9):1925-1926. doi: 10.1038/npp.2017.99. Neuropsychopharmacology. 2017. PMID: 28701746 Free PMC article.
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.
Murphy A, Nestor LJ, McGonigle J, Paterson L, Boyapati V, Ersche KD, Flechais R, Kuchibatla S, Metastasio A, Orban C, Passetti F, Reed L, Smith D, Suckling J, Taylor E, Robbins TW, Lingford-Hughes A, Nutt DJ, Deakin JF, Elliott R. Murphy A, et al. Neuropsychopharmacology. 2017 Apr;42(5):1049-1057. doi: 10.1038/npp.2016.289. Epub 2017 Jan 2. Neuropsychopharmacology. 2017. PMID: 28042871 Free PMC article.
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.
Murphy A, Nestor LJ, McGonigle J, Paterson L, Boyapati V, Ersche KD, Flechais R, Kuchibatla S, Metastasio A, Orban C, Passetti F, Reed L, Smith D, Suckling J, Taylor E, Robbins TW, Lingford-Hughes A, Nutt DJ, Deakin JF, Elliott R; ICCAM Platform. Murphy A, et al. Neuropsychopharmacology. 2017 Jun;42(7):1559. doi: 10.1038/npp.2017.47. Neuropsychopharmacology. 2017. PMID: 28496172 Free PMC article. No abstract available.
Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery.
Savulich G, Riccelli R, Passamonti L, Correia M, Deakin JF, Elliott R, Flechais RS, Lingford-Hughes AR, McGonigle J, Murphy A, Nutt DJ, Orban C, Paterson LM, Reed LJ, Smith DG, Suckling J, Tait R, Taylor EM, Sahakian BJ, Robbins TW, Ersche KD. Savulich G, et al. Transl Psychiatry. 2017 Mar 7;7(3):e1054. doi: 10.1038/tp.2017.34. Transl Psychiatry. 2017. PMID: 28267152 Free PMC article. Clinical Trial.
Assessing human 5-HT function in vivo with pharmacoMRI.
Anderson IM, McKie S, Elliott R, Williams SR, Deakin JF. Anderson IM, et al. Neuropharmacology. 2008 Nov;55(6):1029-37. doi: 10.1016/j.neuropharm.2008.06.029. Epub 2008 Jun 25. Neuropharmacology. 2008. PMID: 18621068 Review.
255 results